Vimarsana
Biggest News Aggregation in the World

Page 20 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

Moderna agrees deal in China with view to developing mRNA medicines - Vimarsana News

Moderna agrees deal in China with view to developing mRNA medicines

Vaccine maker Moderna Inc said on Wednesday it had signed a memorandum of understanding and a land collaboration agreement to work towards opportunities for it to research, develop and manufacture mRNA medicines in China.

China extends squeezed-out foreign pharmaceuticals firms an olive branch - Vimarsana News

China extends squeezed-out foreign pharmaceuticals firms an olive branch

China's Commerce Minister told foreign pharmaceuticals firms they can expect "more development opportunities" during a roundtable on Wednesday, his ministry said, as drugmakers bemoan government procurement policies pricing them out of the market.

Mark Cuban's online pharmacy set to launch Humira biosimilar - Vimarsana News

Mark Cuban's online pharmacy set to launch Humira biosimilar

Mark Cuban Cost Plus Drugs, an online pharmacy launched by the billionaire to sell drugs directly to customers at low prices, should soon begin selling Coherus BioSciences's biosimilar version of AbbVie Inc's blockbuster rheumatoid arthritis drug Humira, Cuban said on Wednesday.

Biden names two Republican nominees for FTC commissioner, White House says - Vimarsana News

Biden names two Republican nominees for FTC commissioner, White House says

U.S. President Joe Biden has nominated Virginia Solicitor General Andrew Ferguson and Utah Solicitor General Melissa Holyoak to fill Republican slots at the Federal Trade Commission, the White House said on Monday.

Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio - Vimarsana News

Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio

Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows, sending the company's shares up over 8% in early trading.